Chronic immune thrombocytopentic purpura in children: Assessment of Rituximab treatment

Journal of Pediatrics

Volumn 148, Issue 3, 2006, Pages 423-

  Taube, Tillmann ^a   von Stackelberg, Arend ^a   Schulte Overberg, Ursula ^a   Henze, Günter ^a   Schmid, Hansjörg ^b   Reinhard, Harald ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB;

CHILD; CHRONIC DISEASE; CONTROLLED STUDY; DRUG SCREENING; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LETTER; PRIORITY JOURNAL; RELAPSE; THROMBOCYTE COUNT;

AGE FACTORS; ANTIBODIES, MONOCLONAL; CHILD; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOLOGIC FACTORS; PURPURA, THROMBOCYTOPENIC; REMISSION INDUCTION;

EID: 33645997637     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2005.10.025     Document Type: Letter

References (7)

1. Cooper N., Stasi R., Cunningham-Rundles S., Feuerstein M.A., Leonard J.P., Amadori S., et al. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br J Haematol 125 (2004) 232-239
2. Braendstrup P., Pedersen M., Bjerrum O.W., Nielsen O.J., Jensen B.A., Nielsaage T.C., et al. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with refractory idiopathic thrombocytopenic purpura. Blood 102 (2003) Abstract 1066.
3. Shanafelt T.D., Madueme H.L., Wolf R.C., and Tefferi A. Rituximab for immune cytopenia in adults. idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome. Mayo Clin Proc 78 (2003) 1340-1346
4. Zaja F., Vianelli N., Sperotto A., De Vita S., Iacona I., Zaccaria A., et al. B-cell compartment as the selective target for the treatment of immune thrombocytopenias. Haematologica 88 (2003) 538-546
5. Giagounidis A.A., Anhuf J., Schneider P., Germing U., Sohngen D., Quabeck K., et al. Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab. a pilot study. Eur J Haematol 69 (2002) 95-100
6. Wang J., Wiley J.M., Luddy R., Greenberg J., Feuerstein M.A., and Bussel J.B. Chronic immune thrombocytopenic purpura in children. assessment of rituximab treatment. J Pediatr 146 (2005) 217-221
7. Taube T., Schmid H., Reinhard H., von Stackelberg A., and Overberg U.S. Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood. Haematologica 90 (2005) 281-283